Browsing by Author "Szigeti, Krisztián"
Now showing 1 - 3 of 3
Results Per Page
Sort Options
- NanoSPECT/MRI: a “new generation” high performance tool in pre-clinical imagingPublication . Metello, Luís F.; Cunha, Lídia; Szigeti, Krisztián; Summavielle, Teresa; Domoko, MatheAbstract Body: PreClinical Imaging it is an each-day evolving field, getting more and more important at distinct areas. The Biotechnology field is between those that taken the biggest benefit. With so much interest, it is not surprising that investment consented on Research and Development is also evolving at the same time that this specific branch of business into the Imaging Industry is getting more and more attention and growing in importance. Hybrid Imaging is also getting more and more interest in the last decade and actually there are different vendors proposing interesting technical solutions, making things easier for one that has the possibilities – and the knowledge about each will be the most adequate for the specific purpose on each situation! – to choose one (or more) of those solutions. This paper relates with the public presentation of images produced from the world first model of a new pre-clinical imaging system, an new equipment that mixes Nuclear Medicine and MRI Magnetic Resonance Imaging techniques, using as base the sub-millimeter Nano-SPECT (Single Photon Emission Computed Tomography), so an high-level performance system – the world reference, produced by MEDISO Company, in Hungary - from Nuclear Medicine and a new MRI component, optimized for Neurosciences, but able to perform adequately on other critical biological fields. As practical example from the possibilities being introduced, images from mice, which are being enrolled on a Neuroscience project, will be showed and will be discussed, but also will be compared with other images being produced on other, actually more current, technical solutions, in order to try to demonstrate the advantages and disadvantages of this specific new approach. Since this small – quick and unpretentious – comparison will be done, it is meant to make possible understanding the place and the real possibilities of this equipment, which it is expected to become available on the world market between the end of this year and the 1st Quarter from next year.
- Preclinical Imaging: an Essential Ally in Modern BiosciencesPublication . Cunha, Lídia; Horvath, Ildiko; Ferreira, Sara; Lemos, Joana; Costa, Pedro; Vieira, Domingos; Veres, Dániel S.; Szigeti, Krisztián; Summavielle, Teresa; Máthé, Domokos; Metello, Luís F.Translational research is changing the practice of modern medicine and the way in which health problems are approached and solved. The use of small-animal models in basic and preclinical sciences is a major keystone for these kinds of research and development strategies, representing a bridge between discoveries at the molecular level and clinical implementation in diagnostics and/or therapeutics. The development of high-resolution in vivo imaging technologies provides a unique opportunity for studying disease in real time, in a quantitative way, at the molecular level, along with the ability to repeatedly and non-invasively monitor disease progression or response to treatment. The greatest advantages of preclinical imaging techniques include the reduction of biological variability and the opportunity to acquire, in continuity, an impressive amount of unique information (without interfering with the biological process under study) in distinct forms, repeated or modulated as needed, along with the substantial reduction in the number of animals required for a particular study, fully complying with 3R (Replacement, Reduction and Refinement) policies. The most suitable modalities for small-animal in vivo imaging applications are based on nuclear medicine techniques (essentially, positron emission tomography [PET] and single photon emission computed tomography [SPECT]), optical imaging (OI), computed tomography (CT), magnetic resonance imaging (MRI), magnetic resonance spectroscopy imaging (MRSI), and ultrasound. Each modality has intrinsic advantages and limitations. More recently, aiming to overcome the inherent limitations of each imaging modality, multimodality devices designed to provide complementary information upon the pathophysiological process under study have gained popularity. The combination of high-resolution modalities, like micro-CT or micro-MRI, with highly sensitive techniques providing functional information, such as micro-PET or micro-SPECT, will continue to broaden the horizons of research in such key areas as infection, oncology, cardiology, and neurology, contributing not only to the understanding of the underlying mechanisms of disease, but also providing efficient and unique tools for evaluating new chemical entities and candidate drugs. The added value of small-animal imaging techniques has driven their increasing use by pharmaceutical companies, contract research organizations, and research institutions.
- The role of molecular imaging in modern drug developmentPublication . Cunha, Lídia; Szigeti, Krisztián; Mathé, Domokos; Metello, Luís F.Drug development represents a highly complex, inefficient and costly process. Over the past decade, the widespread use of nuclear imaging, owing to its functional and molecular nature, has proven to be a determinant in improving the efficiency in selecting the candidate drugs that should either be abandoned or moved forward into clinical trials. This helps not only with the development of safer and effective drugs but also with the shortening of time-to-market. The modern concept and future trends concerning molecular imaging will assumedly be hybrid or multimodality imaging, including combinations between high sensitivity and functional (molecular) modalities with high spatial resolution and morphological techniques.